Defining the usefulness of high CD34+CD38low blast frequency in blood of adult AML patients – a pre-treatment biomarker of poor outcome to standard chemotherapy

Projet: Research project

Détails sur le projet

StatutTerminé
Date de début/de fin réelle1/1/08 → 4/1/19

Financement

  • Social Sciences and Humanities Research Council of Canada: 21 023,00 $ US

ASJC Scopus Subject Areas

  • Environmental Engineering
  • Management, Monitoring, Policy and Law
  • Renewable Energy, Sustainability and the Environment
  • Cancer Research
  • Oncology
  • Health(social science)

Accéder au projet